January 30, 2012
“DENVER–(BUSINESS WIRE)– Cannabis Science, Inc. (OTCBB:CBIS.OB) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, is pleased to share new photographs from this cancer patient with severe squamous cell carcinoma. These pictures clearly show that this patient, with previously treatment-resistant tumors, continues to make obvious improvement. The tumors appear to be dying and then healing after treatment with cannabis-based extracts.”
“Cannabis Science, Inc. (OTCBB: CBIS) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, is very pleased to announce that the second patient suffering from basal cell carcinoma (skin cancer) has self-administered cannabis extracts that appear to have eradicated the cancer.”
“Currently it appears that the aforementioned patient will be able to avoid any surgical procedures such as, standard surgical excision (Mohs Surgery), and other various types of treatment for skin cancer, like chemotherapy, radiation, and cryosurgery, by using the cannabis extracts…”
“Cannabis Science, Inc., a pioneering US biotech company developing pharmaceutical cannabis products, is happy to report an additional, apparently successful, self-medicated cannabis treatment for a cancer patient.
This case is very graphic in nature. One of the patient’s physicians said it was the worst case of squamous cell carcinoma cancer he had ever seen, while another refused to continue tending to the patient.
While this patient’s self-administered treatment with cannabis extracts is still in progress, the results after just two weeks of treatment are dramatic. Some of the tumors have disappeared and others have significantly shrunk to a fraction of their original size. Simultaneously, the patient has had a significant decrease in pain, improved sleeping (the 1st full night of sleep in 3 years), as well as relief from the symptoms of multiple sclerosis that the patient also suffers from. This self-treatment is a work in progress.”
“Cannabis Science, Inc. (OTCBB:CBIS.OB – News) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, is very pleased to announce a second patient suffering skin cancer is self-administering cannabis extracts in collaboration with Cannabis Science.
This patient has photo-documented dramatic results that we will be release to the public once treatment is completed and has been properly vetted by clinical biopsy.”
More: http://eon.businesswire.com/news/eon/20111212006097/en
“This list of peer-reviewed manuscripts, provides support for the anecdotal observations of an increasing number of patients claiming successful cancer treatment using medical cannabis extracts.”
“The scientific documentation of the anti-cancer and anti-metastatic properties of cannabinoids is a driving force behind behind our long-term goal, to make high quality, effective, reliable and safe cannabis extracts available to the public beyond the borders of current medical marijuana states.”
“Cannabis Science Inc. a pioneering US biotech company developing pharmaceutical cannabis products, is pleased to announce that it has been contacted by Lynnice Wedewer, Ph.D. who is a 34 year multiple cancer patient survivor who has been cured of 7 of her 8 cancers in a major part because of medical cannabis.
Dr. Wedewer wishes to share her story through Cannabis Science and help our case and education towards general acceptance of medical cannabis as a natural and viable treatment for cancer.”
More: http://www.reuters.com/article/2011/06/29/idUS207485+29-Jun-2011+BW20110629
April 6, 2011 “We are pleased to announce that we have physician’s documentation that confirms the successful treatment of basal cell carcinoma that resulted from the application of a topical cannabis extract.”
“As we’ve previously reported, one of the most interesting findings that has emerged since the discovery of the endocannabinoid system (marijuana like compounds produced by humans, and all vertebrates) is that cannabinoids have profound cancer-killing and anti-metastatic properties.
There is strong scientific support, demonstrated in tissue culture and animal studies, of the potent cancer killing properties of cannabinoids for such deadly cancers as glioma, lung cancer, breast and prostate cancer, leukemias and lymphomas, and as well as skin cancers.”
“Cannabis Science, Inc. (OTCBB:CBIS), a pioneering US biotech company developing pharmaceutical cannabis products, is pleased to report a government released update on cancer treatments using medical cannabis (marijuana), updated March 17, 2011, summarizing how the treatment of cancer with cannabinoids goes beyond the simple treatment of symptoms and side effects by exhibiting possible direct antitumor activities.
This summary contains the following key information:
– Cannabis has been used for medicinal purposes for thousands of years prior to its current status as an illegal substance.
– Chemical components of Cannabis, called cannabinoids, activate specific receptors found throughout the body to produce pharmacologic effects, particularly in the central nervous system and the immune system.
– Cannabinoids may have benefits in the treatment of cancer-related side effects.
– The potential benefits of medicinal Cannabis for people living with cancer include antiemetic effects, appetite stimulation, pain relief, and improved sleep.
– Though no relevant surveys of practice patterns exist, it appears that physicians caring for cancer patients who prescribe medicinal Cannabis predominantly do so for symptom management.
– Unlike other commonly used drugs, cannabinoids are stored in adipose tissue and excreted at a low rate (half-life 1-3 days).
– Even abrupt cessation of cannabinoid intake is not associated with rapid declines in plasma concentrations that would precipitate severe or abrupt withdrawal symptoms or drug cravings.
Robert Melamede, Ph.D., Cannabis Science’s CEO stated, “As we’ve previously reported, one of the most interesting findings that has emerged since the discovery of the endocannabinoid system (marijuana like compounds produced by humans, and all vertebrates) is that cannabinoids have profound cancer-killing and anti-metastatic properties. There is strong scientific support, demonstrated in tissue culture and animal studies, of the potent cancer killing properties of cannabinoids for such deadly cancers as glioma, lung cancer, breast and prostate cancer, leukemias and lymphomas, and as well as skin cancers.
Currently the federal government prohibitionist position on cannabis is hindering the medical community by delaying vitally important clinical cannabis research.
I was quite elated when I recently saw that the NCI posted on their webpage
“In the practice of integrative oncology, the health care provider may recommend medicinal Cannabis not only for symptom management but also for its possible direct antitumor effect.”
I foolishly thought that finally there would be official recognition of the modern peer reviewed science that shows the cancer killing properties of cannabinoids. Sadly, this statement was removed, without comment, within hours of its posting.””
“Cannabis Science, Inc. a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana derivative) products, is pleased to announce that we have now received verbal confirmation that the sites of the former cancerous lesions are free of cancer cells and we are now awaiting official Physician documentation of the patient’s history and biopsy reports.
Dr. Robert J. Melamede, the CEO and President of Cannabis Science Inc., stated, “The photographic documentation in our last press release, demonstrated that cannabis extracts appeared to be effective against what seems to be the patient’s third incidence of basal cell carcinoma. For accuracy, it should be noted that a before treatment biopsy of the lesion on the nose was not been performed. It is obvious that there was a lesion-centered response to the application of the cannabis extract. This patient had a previous surgically removed lesion, as well as a biopsied basal cell carcinoma on the right cheek. The lesion on the cheek was also self-treated and resolved with cannabis extracts over a half year ago. This deeper cheek lesion did not visually respond like the lesion on the nose, hence there is no photographic record.”
Cannabis Science is committed to making cannabis-based medicines available to the public as rapidly as possible. The Company is taking multiple approaches to accomplishing this aim in the United States. The science of cannabinoids has exploded over the past decade, laying the scientific foundation for the many medicinal uses of this unique plant. Cannabinoids are a class of biologically active compounds produced by all vertebrates, the Cannabis plant, and more recently patentable synthetic compounds produced by chemists. In fact, modern peer-reviewed science supports the many historical uses that were discovered over thousands of years of medicinal use by herbalists.”
“Cannabis Science, Inc. a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana derivative) products, is pleased to announce that numerous patients are reporting that Cannabis Science extract treatments are killing cancer cells.
Unlike most conventional cancer treatments, cannabis has an outstanding safety profile, and patients in states with medical marijuana laws are able to make an informed decision to legally try various cannabis preparations to determine what is most effective for their particular condition.
Some of these scientifically informed patients have chosen to self-administer Cannabis Science extracts supplied by Rockbrook to treat their own cancers. Cannabis Science is delighted that patients are reporting dramatic improvements in their conditions, including basal cell carcinoma, non-small cell lung cancer accompanied by COPD (chronic obstructive pulmonary disease), ovarian cancer, and glioma.”
More: http://www.reuters.com/article/2011/02/22/idUS223662+22-Feb-2011+BW20110222